USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Post-pandemic Global Healthcare Market Outlook, 2020
Stakeholders to Focus on Resource Optimization, New Growth Segments, and Cost Rationalization in a New Era of ‘Healthcare Preparedness’
09-Jul-2020
North America
Market Research
Every year, the team of futurists, analysts, and consultants in Frost & Sullivan's Transformational Healthcare Group comes together to render a comprehensive analysis to predict the themes, technologies, and global forces that will define the next 12 to 18 months (future) for the healthcare industry. In light of the lessons learned from the COVID-19 pandemic and the changing economic and business scenario, Frost & Sullivan has re-visited predictions and identified the top growth opportunities for companies to survive the remainder of 2020. Among the considerations:
• Disrupted clinical trials and the subsequent delay in drug launches will pave the way for fully virtual trials, and hybridization of patient recruitment, retention, and monitoring will become pervasive.
• An increase in point-of-care testing for infectious diseases is inevitable. With the looming change in service models, alternate testing sites such as pharmacies will become permanent ecosystem participants.
• The supply of ventilators and critical care monitoring devices across regions has been uneven during the pandemic, but embedded analytics systems will revive the mature monitoring devices segment post-pandemic.
• A resumption in imaging for the backlog of elective procedures in Q3 and Q4 2020 will be met by teleradiology and artificial intelligence-based solutions gaining from new investments. Scale-up in capacity, flexible payment options, and redistribution of the workload to manage deferrals will determine partnerships.
• A tenfold increase in virtual consultations by healthcare providers is laying the foundation for the new normal. Reimbursement, physician training, and platform scalability will be key to recalibrate care delivery.
Amid the uncertainty, leading healthcare players are adopting risk-mitigation measures and reprioritizing opportunities to recover from the pandemic and rebuild shareholder confidence. While the short-term demand for testing, personal protective equipment, and ventilators remains, and the race to find a vaccine and treatment for COVID-19 continues, healthcare companies must understand what the new normal means for the consumer and prepare a contingency plan to prevent a future healthcare crisis.
As part of this research deliverable, Frost & Sullivan provides bold perspectives for the global healthcare market in 2020. The segments covered include pharmaceuticals and biotech, in vitro diagnostics, medical technologies, medical imaging, and healthcare IT. The analysis captures segment and regional trends and presents predictions for the remainder of 2020. The study provides guidance on where to find the greatest opportunities for expansion in the "Age of the Bio-Economy," which will have significant impact and transformation on economies, societies, and lives.
Author: Unmesh Lal
Covid-19 Impact Summary
Introduction: A New Era of Healthcare Preparedness
Research Scope and Segmentation
Key Questions this Study will Answer
Potential COVID-19 Scenarios
Key Forecast Criteria
Revenue Forecasts in 2 Scenarios
Top 5 Predictions for the 2020 Healthcare Industry
Regional GDP Growth Rate: Geopolitical Shocks
Regional GDP Growth Rate: Geopolitical Shock Trends
Regional GDP Growth Rate: Geopolitical Shock Trends (continued)
Government Response to COVID-19
COVID-19 Impact on World GDP Growth
COVID-19 Impact on World GDP Growth Discussion
Economic Stimulus Measures
COVID-19 Stimulus Trend Analysis
COVID-19 Stimulus Trend Analysis in Selected Countries
COVID-19 Impact on Industries: Struggling, Surviving, and Thriving
Forces Shaping the Healthcare Business Ecosystem
Key Challenges Faced by the Healthcare Industry
COVID-19 Impact on the Healthcare Industry
Global Healthcare Market Revenue: 2019 and 2020
Global Healthcare Market Revenue Forecast Discussion
Global Healthcare Market Revenue Forecast Discussion (continued)
COVID-19 Response Efforts: Impact Assessment
2020 Global Healthcare Stimulus: Developed Markets
2020 Global Healthcare Stimulus: Developed Markets (continued)
2020 Global Healthcare Stimulus: Emerging Markets
2020 Global Healthcare Stimulus: Emerging Markets (continued)
Global Healthcare Company Valuations: Impact Assessment
Life Science Companies: Response and Growth Plans
Life Science Companies: Response and Growth Plans (continued)
Imaging Companies: Response and Growth Plans
Imaging Companies: Response and Growth Plans (continued)
Medical Device/Delivery Companies: Response and Growth Plans
Medical Device/Delivery Companies: Response and Growth Plans (continued)
Healthcare IT Companies: Response and Growth Plans
Healthcare IT Companies: Response and Growth Plans (continued)
2020 Market Snapshot: Pharmaceuticals and Biotechnology
Strategic Imperatives by Product Segment
Key Forecast Trends
Prediction: By the End of 2020, 33% of Global Clinical Trials Will Be Disrupted, Putting $3 Billion in New Product Revenue At Risk
Clinical Trial IT Solutions Enabling Virtualization
Companies to Action
2020 Market Snapshot: In Vitro Diagnostics
Strategic Imperatives by Product Segment
Key Forecast Trends
Prediction: Alternate Testing Sites to Change the POCT Service Paradigm for the $5 Billion Infectious Diseases Market
Demand for COVID-19 POCT
Companies to Action
2020 Market Snapshot: Medical Technologies
Strategic Imperatives by Product Segment
Key Forecast Trends
Prediction: 3X Ventilator Surplus and Remote Monitoring Will Redefine the Non-hospital and Home Critical Care Model
Resetting Priority for Critical Care Medicine
Companies to Action
2020 Market Snapshot: Medical Imaging Equipment
Strategic Imperatives by Product Segment
Key Forecast Trends
Prediction: Informatics and AI Solutions Addressing Workflow Automation, and Operational Analytics Will Witness 100% Growth In 2020
Acceleration of Innovative Customer-Vendor Partnership and PPP Models
Companies to Action
2020 Market Snapshot: Healthcare IT
Strategic Imperatives by Product Segment
Key Forecast Trends
Prediction: Virtual Consultations Will Witness Greater Than 100% Growth in the United States
Telehealth as a Mainstream Delivery Model
Companies to Action
Companies to Action (continued)
Conclusions
Pandemic Driving Restructuring of Healthcare Companies
Risk Mitigation Strategy Timeline
Respond, Reset, and Rebound
COVID-19 Healthcare Strategy Partnership
Take the COVID-19 Growth Pipeline Diagnostic
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
About the Growth Pipeline Engine™
Market Definition: Pharmaceuticals and Biotechnology
Market Definition: In Vitro Diagnostics
Market Definition: Medical Technologies
Market Definition: Medical Technologies (continued)
Market Definition: Medical Imaging Equipment
Market Definition—Healthcare IT
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Unmesh Lal |
| Industries | Healthcare |
| WIP Number | MF6E-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9564-B1,9575-B1,9600-B1,9612-B1,9825-B1,9A51-B1,9A52-B1,9A54-B1,9A06-B1,9A55-B1,9562-B1,9566-B1,9570-B1,9571-B1,9573-B1,99BB-B1,99BC-B1,99BD-B1,99BF-B1,99C0-B1,99C1-B1,99C6-B1,99C9-B1,99CB-B1,99CC-B1,9A47-B1,9A48-B1,9A49-B1,9A4B-B1,99BE-B1,9568-B1,9611-B1 |